Systemic lupus erythematosus (CNS manifestations)
WebMay 7, 2024 · Last revised by Joshua Yap on 7 May 2024. Edit article. Citation, DOI, disclosures and article data. Central nervous system manifestations of systemic lupus erythematosus (CNS lupus), also known as neuropsychiatric systemic lupus erythematosus (NPSLE), describe a very diverse range of neuropsychiatric manifestations that are …
Systemic lupus erythematosus - Latest research and news | Nature
WebMay 3, 2024 · Systemic lupus erythematosus articles from across Nature Portfolio. Systemic lupus erythematosus is a potentially fatal autoimmune disease that is characterized by wide-spread...
Lupus - Wikipedia
Web5 days ago · 15 year survival ~80% [3] Frequency. 2–7 per 10,000 [2] Lupus, technically known as systemic lupus erythematosus ( SLE ), is an autoimmune disease in which the body's immune system mistakenly attacks healthy tissue in many parts of the body. [1] Symptoms vary among people and may be mild to severe. [1]
WebMay 21, 2024 · See rights and permissions. Published by BMJ on behalf of EULAR.”. ABSTRACT Objectives To analyse the new evidence (2018–2022) for the management of systemic lupus erythematosus (SLE) to inform the 2023 update of the European League Against Rheumatism (EULAR) recommendations.
(READ) FDA approves new drug for autoimmune lupus disorder SLE
Web6 days ago · It’s the first approved drug of its kind, and the only new treatment for SLE in more than a decade, according to Astra Zeneca. SLE is a form of autoimmune disorder affecting more than 300,000 people in the U.S. The drug is anifrolumab, an inhibitor of type 1 interferons. It will be sold as Saphnelo.
Efficacy and safety study of targeted small-molecule drugs in the ...
WebMay 10, 2024 · This is the first network meta-analysis of targeted small-molecule drugs in the treatment of SLE to compare the difference in efficacy and safety among various targeted small-molecule drugs. Meanwhile, the effect of the dose and the course of treatment on efficacy and safety was also considered.
Lupus (SLE) in Children, Pediatric Lupus: Causes & Treatment
WebMay 6, 2024 · Systemic lupus erythematosus (SLE) is the most common type of lupus among children and adults. And it’s what most people mean when they talk about lupus in children. Other terms that refer to lupus in children include: Childhood-onset lupus, or childhood-onset SLE. Juvenile-onset lupus, or juvenile-onset SLE. Pediatric lupus.
Symptoms of Lupus | Lupus | CDC
WebMay 15, 2024 · Key points. Lupus is a long-term disease that can affect any part of the body. People with lupus can have many different symptoms. They may experience periods of increased symptoms (flares) or no symptoms at all (remission).
Disease-modifying therapies in systemic lupus erythematosus for ...
WebMay 22, 2024 · Our 2022 published working definition of disease modification in systemic lupus erythematosus (SLE) was 'minimising disease activity with the fewest treatment-associated toxicities and slowing or preventing organ damage progression'. The objective of this review was to classify current SLE treatment …
Pediatric Systemic Lupus Erythematosus Workup - Medscape
Web3 days ago · Next: Imaging Studies. Systemic lupus erythematosus (SLE) is a rheumatic disease characterized by autoantibodies directed against self-antigens, immune complex formation, and immune dysregulation, resulting in damage to essentially any organ. The disease can affect, for example, the kidneys, skin, blood cells, and nervous system.
- Some results have been removed
Skip to content